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Abstract 
MassTag PCR is a novel technology for the rapid, sensitive and simultaneous detection of multiple 
gene sequences. This technique, developed at the Center for Infection and Immunity (CII) at 
Columbia University, utilises a library of unique tags, each unique its molecular weight. MassTags 
are conjugated to oligonucleotide primers using a UV-cleavable linker that enables separation of 
primer and tag. Primers are labelled with a unique molecular weight tag and are used to amplify 
target nucleic acids in a multiplex RT-PCR. After removing unincorporated primers, tags are 
released by UV irradiation and analysed by mass spectrometry. Thus, amplification of the gene 
target produces a unique dual signal in mass spectrometry analysis that allows its identification. 
MassTag PCR offers an inexpensive and sensitive diagnostic platform suitable for high-throughput 
testing, and that can be adapted to suit diagnostic needs (e.g., syndrome-, vector-based). To date, 
MassTag PCR panels have been developed for the detection of respiratory pathogens and viruses 
that cause haemorrhagic fever. A third MassTag PCR assay is being developed to identify microbial 
agents that cause neurological disease in a North American/European diagnostic setting. In 
collaboration with the CII and PathWest Laboratory Medicine, we have begun modifying and 
developing this assay to address pathogens relevant to the Australasian region. Initial research has 
involved extensive bioinformatics analyses for the design of primer sets that are specific only for 
the cognate target pathogen and that will not cross-hybridise with existing primers comprising the 
panels. This has been followed by in vitro evaluation of multiplex panels using untagged primers 
and agarose gel analysis. Preliminary research experiences and progress towards development of 
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